5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-amine, 95.0%, 10g

2-aminofenol, mínimo 99 %, para síntesis, 100 g, envase de vidrio

(pentylsulfanyl)methanimidamide hydrobromide, 95.0%, 1g

N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine, 50mg

3-Methyl-1-(pyridin-2-yl)-1H-pyrazole-5-carboxylic acid, 1g

5-[4-[4-(5-Formylthiophen-2-yl)-N-[4-(5-formylthiophen-2-yl)phenyl]anilino]phenyl]thiophene-2-carbaldehyde, 97%, 1g

1-(2-Methoxyphenyl)-4-methyl-1H-pyrazol-5-amine, 1g

5-Bromo-2,4-difluorobenzoic acid, 95.0%, 500g

ETHYL 6-BROMO-1H-INDAZOLE-3-CARBOXYLATE, 95%, 100mg

8-Nonen-1-ol>98.0%(GC)25g

2-chloro-N-ethylnicotinamide, 95.0%, 10g

6-Bromo-2-methyloxazolo[4,5-b]pyridine, 95.0%, 5g

4-Chloro-3-nitrobenzenesulfonic acid, 95.0%, 25g